Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Kidney International

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.2008.108PMID 18385667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.

  2009cited by this paper
• International uniform response criteria for multiple myeloma

  2007cited by this paper
• Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

  2007cited by this paper
• Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.

  2007cited by this paper
• Renal manifestations of plasma cell disorders.

  2007cited by this paper
• International uniform response criteria for multiple myeloma

  2006cited by this paper
• Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

  2006cited by this paper
• A proliferative glomerulonephritis secondary to a monoclonal IgA.

  2006cited by this paper
• Plasma exchange in multiple myeloma.

  2006cited by this paper
• Plasma Exchange When Myeloma Presents as Acute Renal Failure

  2005cited by this paper
• Light chain deposition disease of the kidney. Morphological aspects in 24 patients

  2004cited by this paper
• Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.

  2004cited by this paper
• Monoclonal gammopathy: significance and possible causality in renal disease.

  2003cited by this paper
• Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

  2001cited by this paper
• RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY

  2000cited by this paper
• Renal failure in multiple myeloma: reversibility and impact on the prognosis

  2000cited by this paper
• Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.

  2000cited by this paper
• Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

  1998cited by this paper
• Multiple myeloma presenting as proliferative (crescentic) glomerulonephritis.

  1994cited by this paper
• Multiple myeloma presenting as proliferative (crescentic) glomerulonephritis.

  1994cited by this paper
• Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

  1993cited by this paper
• Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.

  1991cited by this paper
• Renal failure in multiple myeloma. Pathogenesis and prognostic implications.

  1990cited by this paper
• Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.

  1990cited by this paper
• Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.

  1990cited by this paper
• Renal Failure in Multiple Myeloma

  1990cited by this paper
• Controlled plasma exchange trial in acute renal failure due to multiple myeloma.

  1988cited by this paper
• Light chain nephropathy: histological and clinical aspects in 15 cases.

  1988cited by this paper
• Multiple Myeloma and Severe Renal Failure: A Clinicopathologic Study of Outcome and Prognosis in 34 Patients

  1987cited by this paper
• Successful treatment of myeloma kidney by diuresis and plasmaphoresis.

  1976cited by this paper

• High cut-off haemodialysis for dialysis dependent myeloma cast nephropathy at first presentation: A case series

  2026cites this paper
• Treatment of Renal Failure Due to Multiple Myeloma by Plasmapheresis Adjunctive to Chemotherapy: A Systematic Review

  2026cites this paper
• The Role of Therapeutic Plasma Exchange in the Management of Myeloma-Related Cast Nephropathy: A 10-Year Real-World Cohort Study

  2026influential citation
• Therapeutic Plasma Exchange Experience in Internal Medicine Clinics: a Retrospective Review of 1,048 Procedures

  2025cites this paper
• Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease

  2025cites this paper
• The role of extracorporeal therapy in light chain cast nephropathy.

  2025cites this paper
• Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy

  2025cites this paper
• Evaluation of Light Chain Removal Rates in Blood Purification Therapy for Light Chain Cast Nephropathy

  2025cites this paper
• Bibliometric and Bioinformatics Analysis of Renal Impairment in Multiple Myeloma: Trends and Research Hotspots, and Associated Genetic Pathways (2000-2023)

  2025cites this paper
• Developing antisense therapeutics for multiple myeloma

  2025cites this paper
• Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery

  2024cites this paper
• Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian Cohort

  2024cites this paper
• The role of therapeutic plasma exchange in plasma cell disorders

  2024cites this paper
• Kidney disease in multiple myeloma.

  2024cites this paper
• Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment-An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse.

  2024cites this paper
• Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study

  2024cites this paper
• Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy

  2024cites this paper
• Recent Updates in the Diagnosis and Management of Kidney Diseases in Multiple Myeloma

  2024cites this paper
• High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: PRO

  2023cites this paper
• [Renal failure in multiple myeloma: Specific management issues].

  2023cites this paper
• A Study on Renal Failure Management in Patients Diagnosed With Multiple Myeloma

  2023cites this paper
• Real-life experience with plasmapheresis in newly diagnosed multiple myeloma accompanied by acute kidney injury

  2023cites this paper
• Multiple myeloma with acute light chain cast nephropathy

  2023influential citation
• Malignancy diseases and kidneys: A nephrologist prospect and updated review

  2023cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

  2023cites this paper
• Pushing the boundaries of hemodialysis: innovations in membranes and sorbents.

  2023cites this paper
• Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study

  2023cites this paper
• Management of Renal Failure in Multiple Myeloma

  2023cites this paper
• Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report

  2023cites this paper
• Role of light chain clearance in the recovery of renal function in multiple myeloma: another point of view

  2023cites this paper
• Therapeutic Apheresis, Immunosuppression, and Human Monoclonal Antibodies in Hematologic Diseases

  2023cites this paper
• Acute renal failure as a manifestation of multiple myeloma frequency and clinical implications

  2023cites this paper
• Therapeutic Plasma Exchange: For Cancer Patients

  2022cites this paper
• Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management

  2022cites this paper
• Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.

  2022cites this paper
• Paraproteinämien und Nierenbeteiligung

  2022cites this paper
• Therapeutic Apheresis, Immunosuppression and Human Monoclonal Anti-bodies in Hematologic diseases most with im-munologic origin

  2022cites this paper
• Multiple Myeloma and Acute Kidney Injury: Mechanisms Involved

  2022cites this paper
• Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion

  2022influential citation
• Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease

  2022cites this paper
• Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges

  2022influential citation
• Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney

  2022cites this paper
• RATIONAL DESIGN, SYNTHESIS AND IN VITRO EVALUATION OF N-(4-ETHOXYPHENYLSULFONYL)-L-GLUTAMIC ACID ANALOGUES AS ANTIANGIOGENIC AND ANTICANCER AGENTS ON MULTIPLE MYELOMA

  2021cites this paper
• Therapeutic Plasma Exchange in the Critically Ill Patient: Technology and Indications.

  2021cites this paper
• Management of acute kidney injury in symptomatic multiple myeloma.

  2021cites this paper
• Acute Kidney Injury in Monoclonal Gammopathies

  2021cites this paper
• Effect of high cut-off dialysis for acute kidney injury secondary to cast nephropathy in patients with multiple myeloma: a systematic review and meta-analysis

  2020cites this paper
• Cancer and Chronic Kidney Disease

  2020cites this paper
• Trends in the use of therapeutic plasma exchange in multiple myeloma

  2020cites this paper
• Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma

  2020cites this paper
• Streptococcal Pharyngitis

  2020cites this paper
• Multiple Myeloma in Older Adults

  2020cites this paper
• Hemodia ltration with ultra ltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients

  2020cites this paper
• Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: A multicenter retrospective study.

  2020cites this paper
• Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury

  2020cites this paper
• Perspectives From an Onconephrology Interest Group: Conference Report

  2020cites this paper
• Renal failure in multiple myeloma and its treatment.

  2020cites this paper
• ERKRANKUNGEN DER NIERE

  2020cites this paper
• Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients

  2020cites this paper
• Dysproteinemias

  2020cites this paper
• Paraneoplastic glomerular diseases

  2020cites this paper
• Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study

  2020cites this paper
• Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy.

  2020cites this paper
• The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation

  2020cites this paper
• Wikilite 26-An overview of the kidney and monoclonal free light chains 26 . 1

  2019cites this paper
• Light chain removal strategies in cast nephropathy

  2019cites this paper
• The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies

  2019cites this paper
• Acute kidney injury in the patient with cancer

  2019influential citation
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cites this paper
• Myeloma light chain cast nephropathy, a review

  2019cites this paper
• Therapeutic Plasma Exchange in Renal Disorders

  2019cites this paper
• Therapeutic plasma exchange - A brief review of indications, urgency, schedule, and technical aspects.

  2019cites this paper
• Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney—What We Know and What the Future May Hold

  2018cites this paper
• A population‐based study of the impact of dialysis on mortality in multiple myeloma

  2018cites this paper
• Role of Plasmapheresis in the Management of Acute Kidney Injury in Patients With Multiple Myeloma: Should We Abandon It?

  2018cites this paper
• Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy

  2018cites this paper
• Treatment of multiple myeloma with renal involvement: the nephrologist’s view

  2018cites this paper
• Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series

  2018cites this paper
• Plasma exchange in the management of new onset multiple myeloma with cast nephropathy treated with bortezomib based chemotherapy

  2017cites this paper
• Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial

  2017cites this paper
• Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury

  2017influential citation
• 6. Myeloma cast nephropathyに対する最適な治療戦略

  2017cites this paper
• Scorpion sting nephropathy: A case report

  2017cites this paper
• [Current approaches to treating of patients with multiple myeloma with renal failure: Questions and proofs].

  2017cites this paper
• Bubrežna insuficijencija u osoba s multiplim mijelomom

  2017cites this paper
• AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity

  2017cites this paper
• Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies

  2017cites this paper
• Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.

  2016cites this paper
• High Cut Off Hemodialysis

  2016cites this paper
• Extracorporeal Removal of Serum-Free Light Chains in Patients with Multiple Myeloma-Associated Acute Kidney Injury

  2016cites this paper
• To biopsy or not to biopsy, that is the question in myeloma cast nephropathy.

  2016cites this paper
• ‘Patients with multiple myeloma have excellent long‐term outcomes after recovery from dialysis‐dependent acute kidney injury’

  2016cites this paper
• Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange

  2016cites this paper
• What are the Newer Applications for Therapeutic Apheresis in Nephrology?

  2016cites this paper
• Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.

  2016cites this paper
• Non-Secretory Myeloma, Diagnosed on Renal Biopsy as Cast Nephropathy.

  2016cites this paper
• Laboratory testing in monoclonal gammopathy of renal significance (MGRS)

  2016cites this paper
• Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology

  2016cites this paper
• Current Trends of Renal Impairment in Multiple Myeloma

  2016cites this paper
• Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents

  2016cites this paper